Rob Hopfner

Rob Hopfner

Managing Director and Managing Partner atPivotal Life SciencesSan Francisco

Rob Hopfner is a Managing Director at Pivotal Life Sciences and Managing Partner at Pivotal bioVenture Partners. He has experience in venture investing and pharmaceutical business development.

What Rob can write

Writes checks ofNot reported
Comes in atNot reportedLead preference not reported
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. DuPont / Merck Pharmaceuticals
  2. Bay City Capital · Managing Director
  3. Pivotal Life Sciences · Managing Director
    Now
  4. Pivotal bioVenture Partners (US) · Managing Partner

Investments named in public bios

Aciex TherapeuticsArcutis TherapeuticsAvalyn PharmaCivitas TherapeuticsDermiraExscientiaGracellHyperion TherapeuticsInozymeKaruna TherapeuticsLB PharmaMadrigal PharmaceuticalsMerus BVNextWave PharmaceuticalsObsidian TherapeuticsOculis

Focus

Venture Capital

Education

University of Saskatchewan, RPh in Pharmacy and PhD in PharmacologyUniversity of Chicago Booth School of Business, MBAHarvard Medical School

Also at Pivotal Life Sciences

Alert me when Pivotal Life Sciences is active

One email when Rob's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Rob Hopfner?

Rob Hopfner is a Managing Director at Pivotal Life Sciences and Managing Partner at Pivotal bioVenture Partners. He has experience in venture investing and pharmaceutical business development.

How much does Rob Hopfner invest?

Pivotal Life Sciences has not reported a check size.

How do I pitch Rob Hopfner?

A warm intro from a founder Pivotal Life Sciences backed works best.

What did Rob Hopfner do before Pivotal Life Sciences?

DuPont / Merck Pharmaceuticals; Managing Director at Bay City Capital; Managing Partner at Pivotal bioVenture Partners (US).

Last updated 2026-10-15. Is this you? Ask for a correction.